Notch-signaling and nonmelanoma skin cancer: An ancient friend, revisited

Advances in Experimental Medicine and Biology

Volumn 727, Issue , 2012, Pages 265-271

  Reichrath, Jörg ^a   Reichrath, Sandra ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JAGGED1; NOTCH RECEPTOR; NOTCH1 RECEPTOR; PROTEIN P21;

APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CELL DIFFERENTIATION; CELL PROLIFERATION; CUTANEOUS SQUAMOUS CELL CARCINOMA; GENE; GENE DELETION; HUMAN; KERATINOCYTE; MELANOMA; NONHUMAN; NOTCH1 GENE; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION; SKIN CANCER; SKIN CARCINOGENESIS; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; ANIMAL; METABOLISM; PATHOLOGY; REVIEW; SKIN TUMOR;

ANIMALS; HUMANS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 84859484455     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0899-4_20     Document Type: Article

References (43)

1. Artavanis-Tsakonas S, Rand MD, Lake RJ. Notch signaling: Cell fate control and signal integration in development. Science 1999; 284:770-776.
2. Kolev V, Mandinova A, Guinea-Viniegra J et al. EOFR signalling as a negative regulator of Notch 1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol 2008; 10(8):902-91 1.
3. Moriyama M, DurhamAD, MoriyamaH et al. Multiple roles of Notch signaling in the regulation of epidermal development. Dev Cell 2008; 14(4):594-604.
4. Lefort K, Dotto OP. Notch signaling in the integrated control of keratinocyte growth differentiation and tumor suppression. Semin Cancer Biol 2004; 14:374-386.
5. Rangarajan A, Talora C, Okuyama Ret al. Notch signaling is a direct determinant of keratinocyte growth anest and entry into differentiation. EMBO J 2001; 20:3427-3436.
6. Okuyama R, Nguyen BC, Talora C et al. High commitment of embryonic keratinocytes to terminal differentiation through a Notch1-caspase 3 regulatory mechanism. Dev Cell 2004; 6:551-562.
7. Lai EC. Notch signaling: Control of cell communication and cell fate. Development 2004; 131:965-973.
8. Kadesch T. Notch signaling: The demise of elegant simplicity. Curr Opin Genet Dev 2004; 14:506-512.
9. Nicolas M, Wolfer A, Raj K et al. Notch 1 functions as a tumor suppressor in mouse skin. Nat Genet 2003; 33:416-42 1.
10. Kiec-Willc B, Orzybowska-Oaluszka J, Polus A et al. The MAPK-dependent regulation of the Jagged1 Notch gene expression by VEOF, bFOF or PPAR gamma mediated angiogenesis in HUVEC. J Physiol Pharmacol 2010; 61(2):217-225.
11. ZhangY, Li B, Ji ZZ et al. Notchregulatesthe growth ofhumancoloncancers. Cancer 2010; 116:5207-5218.
12. Wang Z, Li Y, Ahmad Aet al. Down-regulation of Notch-1 is associated with Akt and FoxMi in inducing cell growth inhibition and apoptosis in prostate cancer cells. J Cell Biochem 2010; 112:78-88.
13. Rubin AT, Chen EH, Ratner D. Basal-cell carcinoma. N Engl J Med 2005; 353:2262-2269.
14. Bagheri MM, Safai B. Cutaneous malignancies of keratinocytic origin. Clin Dermatol 2001; 19:244-252.
15. Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engi J Med 2001; 344:975-983.
16. Reichrath J, Nllrnberg B. Solar UV-radiation, vitamin D and skin cancer surveillance in organ transplant recipients (OTRs). Adv Exp Med Biol 2008; 624:203-2 14.
17. Green CL, Khavari PA. Targets for molecular therapy of skin cancer. Semin Cancer Biol 2004; 14:63-69.
18. Oro AE, Higgins KM, Hu Z et al. Basal cell carcinomas in mice over expressing sonic hedgehog. Science 1997; 276:817-821.
19. Melnikova VO, Ananthaswamy HN. Cellular and molecular events leading to the development of skin cancer. Mutat Res 2005; 571:91-106.
20. Tsai KY, Tsao H. The genetics of skin cancer. Am J Med Genet C Semin Med Genet 2004; 131C:82-92.
21. Weng AP, Aster JC. Multiple niches for Notch in cancer: Context is everything. Cun Opin Genet Dev 2004; 14:48-54.
22. Lowell S, Jones P, Le Roux Jet al. Stimulation of human epidermal differentiation by delta-notch signalling at the boundaries of stem-cell clusters. Cun Biol 2000; 10:49 1-500.
23. Lai EC. Keeping a good pathway down: Transcriptional repression of Notch pathway target genes by CSL proteins. EMBO Rep 2002; 3:840-845.
24. Wu L, Maillard I, Nakamura Met al. The transcriptional coactivator Maml 1 is required for Notch2-mediated marginal zone B-cell development. Blood 2007; 110(10):3618-3623.
25. Iso T, Kedes L, Hamamori Y. HES and HERP families: Multiple effectors of the Notch signaling pathway. J Cell Physiol 2003; 194:237-255.
26. Thelu J, Rossio P, Favier B. Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing. BMC Dermatol 2002; 2:7.
27. Radtke F. Raj K. The role of Notch in tumorigenesis: Oncogene or tumour suppressor? Nat Rev Cancer 2003; 3:756-767.
28. Massi D, Tarantini F, Franchi A et al. Evidence for differential expression of Notch receptors and their ligands in melanocytic nevi and cutaneous malignant melanoma. Modern Pathology 2006; 19:246-254.
29. Pinnix CC, Herlyn M. The many faces of Notch signaling in skin-derived cells. Pigment Cell Res 2007; 20:45 8-465.
30. Wuest M, Dummer R, Urosevic M. Induction of the members of Notch pathway in superficial basal cell carcinomas treated with imiquimod. Arch Dermatol Res 2007; 299(10):493-498.
31. Carmody RJ, ChenYH. Nuclear factor-kappaB: Activation andregulation during toll-like receptor signaling. Cell Mol Immunol 2007; 4:31-41.
32. Urosevic M, Dummer R. Role ofimiquimod in skin cancertreatment. Am J Clin Dermatol 2004; 5:453-458.
33. Urosevic M, Dummer R, Conrad C et al. Disease-independent skinrecruitment andactivationofplasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst 2005; 97:1143-1153.
34. Osborne BA, Minter LM. Notch signalling during peripheral T-cell activation and differentiation. Nat Rev Immunol 2007; 7:64-75.
35. Koch U, Radtke F. Notch and cancer: A double-edged sword, Cell Mol Life Sci 2007; 64:2746-2762.
36. Demehri S, Turkoz A, Kopan R. Epidermal Notch 1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 2009; 1:55-66.
37. Zoumpourlis V, Solakidi S, Papathoma Aet al. Alterations in signal transduction pathays implicated in tumour progression during multistage mouse skin carcinogenesis, Carcinogenesis 2003; 24:1159-1165.
38. Weinberg WC, Fernandez-Salas E, Morgan DL et al. Genetic deletion ofp2iWAFi enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis, Cancer Res 1999; 59: 2050-2054.
39. Lee J, Basak JM, Demehri Set al. Bi-compartmental communication contributes to the opposite proliferative behaviorofNotch1-deficienthairfollicle andepidermalkeratinocytes, Development2007; 134:2795-2806.
40. Orimo A, Weinberg RA. Stromal fibroblasts in cancer: A novel tumor-promoting cell type, Cell Cycle 2006; 5:1597-1601.
41. Vauclair S, Majo F, Durham AD et al. Corneal epithelial cell fate is maintained during repair by Notch1 signaling via the regulation of vitamin A metabolism, Dev Cell 2007; 13:242-253.
42. Watt FM, Estrach S, Ambler CA. Epidermal Notch signalling: Differentiation, cancer and adhesion, Cun Opin Cell Biol 2008; 20:171-179.
43. BissellMj, Radisky D. Putting tumours in context, Nat Rev Cancer 2001; 1:46-54.